[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353943-105":59,"doc-detail-353943-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","impact-of-bmi-on-organs-at-risk-dose-for-cervical-cancer-treated-with-definitive-radiation-therapy-followed-by-brachytherapy-boost","Impact of BMI on Organs at Risk Dose for Cervical Cancer Treated With Definitive Radiation Therapy Followed by Brachytherapy Boost","","Higher BMI is linked to protective effects in intracavitary brachytherapy for cervical cancer, yet its influence on organs at risk (OAR) dosing is unclear under hybrid intracavitary-interstitial applicators. Patients receiving definitive chemoradiation and brachytherapy boosts from 2023–2025 were analyzed using linear mixed effects regression. Across 56 patients and 221 plans, BMI showed an inverse association with small bowel and bladder dose metrics during brachytherapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/impact-of-bmi-on-organs-at-risk-dose-for-cervical-cancer-treated-with-definitive-radiation-therapy-followed-by-brachytherapy-boost/353943/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/impact-of-bmi-on-organs-at-risk-dose-for-cervical-cancer-treated-with-definitive-radiation-therapy-followed-by-brachytherapy-boost/353943.png","ImageObject",300,407,{"name":92,"@type":93},"Kyle","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study objective regarding BMI and cervical cancer brachytherapy?","Question",{"text":112,"@type":113},"To determine how body mass index (BMI) relates to dose delivered to organs at risk during brachytherapy for cervical cancer treated with definitive radiation therapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were brachytherapy doses to OARs quantified in the study?",{"text":117,"@type":113},"Brachytherapy doses to OAR volumes of 0.1cm3, 1cm3, and 2cm3 were recorded as percentages of the prescription dose (%Rx).",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about the relationship between BMI and OAR doses?",{"text":121,"@type":113},"After adjusting for other variables, increasing BMI was associated with decreased small bowel and bladder doses during brachytherapy, while no similar pattern was seen for rectum and sigmoid.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353943,1790645635,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},3985741905716,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Review began 02/04/2026  \nReview ended 02/24/2026  \nPublished 02/26/2026  \n© Copyright 2026  \nTang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0. , which permits unrestricted use , distribution , and reproduction in any medium , provided the original author and source are credited.  \nDOI: 10.7759/cureus.104301  \nOpen Access Original Article  \nImpact of BMI on Organs at Risk Dose for Cervical Cancer Treated With Definitive Radiation Therapy Followed by Brachytherapy Boost  \nJustin Tang 1, Caroline Oska 1, Xianhong Xie 2 , Ilan Small 3, Keyur J. Mehta 1, Ryung S. Kim 2 , Ravindra Yaparpalvi 1  \n1. Radiation Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, USA 2. Epidemiology and Public Health, Albert Einstein College of Medicine, Bronx, USA 3. Radiation Oncology, Albert Einstein College of Medicine, Bronx, USA  \nCorresponding author: Justin Tang, [jtang@montefiore.org](jtang@montefiore.org)  \nAbstract  \nObjective  \nHigher body mass index (BMI) is identified as a protective factor in intracavitary brachytherapy (BT) for cervical cancer (CC) treated with definitive radiation therapy, particularly for gastrointestinal toxicity. The impact of BMI on organs at risk (OAR) dose remains unknown as hybrid intracavitary-interstitial applicators are used.  \nMethods  \nPatients with CC who received definitive chemoradiation followed by BT boosts from 2023 to 2025 were included. BT doses to OAR of 0 .1cm3, 1cm3, and 2cm3 were collected as % of the prescription dose (%Rx) . Alinear mixed effects regression model was fitted to evaluate the relationship between BMI and dose to OARs.  \nResults  \nFifty-six patients with 221 BT plans were included. The majority of patients included were 2018 International Federation of Gynecology and Obstetrics (FIGO) stage IIIC (n = 29, 51.8%) . The mean ± standard deviation (SD) of BMI for the cohort was 29.4 ± 7.6 kg/m2, with 36 (64 .3%) patients receiving hybrid BT with a median (interquartile range (IQR)) of 2 (2-3) needles. The mean ± SD of D0.1cm3, D 1cm3, and D2cm3 %Rx for rectum were 55.4% ± 18.6, 45% ± 15.4, and 41 .4% ± 13.9 ; for sigmoid were 63.9% ± 17.2, 52.5% ± 14.3, and 47.8% ± 13.3 ; for bladder were 83.3% ± 13.6, 71.0% ± 11.2, and 65.6% ± 10.6 ; and for small bowel (SB) were 51.4% ± 22.9, 42. 1% ± 19.6, and 38.0% ± 17.5, respectively. While controlling for other variables, each one-point increase in BMI decreased the small bowel D0.1cm3, D 1cm3, and D2cm3 by 0.91, 0.78, and 0 .72, respectively (p = 0 .008 for D0.1cm3, and 0 .006 for D1cm3 and D2cm3) . The bladder D1cm3 and D2cm3 decreased by 0.31 (p=0 .030) and 0 .32 (p=0 .017), respectively. The same was not true for the rectum and sigmoid.  \nConclusion  \nWe found an inverse relationship between BMI and dose to the small bowel and bladder during BT.  \nCategories: Obstetrics/Gynecology, Medical Physics, Radiation Oncology  \nKeywords: bmi, brachytherapy, cervix, hdr ir-192, hybrid applicator  \nIntroduction  \nThe standard treatment for locally advanced cervical cancer (LACC) is external beam radiotherapy (EBRT)  \nand concurrent chemotherapy followed by brachytherapy (BT) boost with or without immunotherapy [1] .  \nImage-guided brachytherapy (IGBT) is a modern technique that achieves excellent outcomes for LACC while sparing organs at risk (OAR) in several studies [2-5]. However, while advancements in BT limit severe treatment toxicities, mild morbidities and their impact on patient quality of life remain prevalent [6] .  \nEMBRACE-1 was a prospective, observational, cohort study evaluating local control (LC) and late morbidity for patients with LACC treated with chemoradiotherapy followed by MRI-based IGBT [7] . They achieved an actuarial five-year LC rate of 92%(similar across all International Federation of Gynecology and Obstetrics (FIGO) stages) and rates of grade 3-5 genitourinary, gastrointestinal (GI), and vaginal morbidity of 6.8%, 8.5%, a","cbCaisy0ZQIqCzH4","https://ap.wps.com/l/cbCaisy0ZQIqCzH4","pdf",453322,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Background and rationale\n## Prior studies and toxicity burden\n## Factors affecting gastrointestinal toxicity","[{\"question\":\"What is the study objective regarding BMI and cervical cancer brachytherapy?\",\"answer\":\"To determine how body mass index (BMI) relates to dose delivered to organs at risk during brachytherapy for cervical cancer treated with definitive radiation therapy.\"},{\"question\":\"How were brachytherapy doses to OARs quantified in the study?\",\"answer\":\"Brachytherapy doses to OAR volumes of 0.1cm3, 1cm3, and 2cm3 were recorded as percentages of the prescription dose (%Rx).\"},{\"question\":\"What did the study find about the relationship between BMI and OAR doses?\",\"answer\":\"After adjusting for other variables, increasing BMI was associated with decreased small bowel and bladder doses during brachytherapy, while no similar pattern was seen for rectum and sigmoid.\"}]","Impact of BMI on Organs at Risk Dose for Cervical Cancer Treated With Definitive Radiation Therapy Followed by Brachytherapy Boost | PDF",1790108082,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3769c21d910d9345dafce3c6a98b0184.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/78a423a6e3ebd688bae24484d302f0eb.webp",982,1389,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2271061e796a4424d31d100137c71c43.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/510542e21054791858aa211b50fbffb5.webp",980,1386]